Board of Directors
VINCE GAO, PHD
Founder & CEO
Dr. Vince Gao, Founder, and serves as Chief Executive Officer, has more than 18 years of experience in leading life science R&D and business. Dr. Gao has a deep passion for using high-technology to improve people’s health and quality of life, and increase the value of wellness services. Most recently he served as the Executive President of Health Division of BGI, the world largest genomics company, where he pioneered the MS-Seq test for inborn errors of metabolism won the Top 10 Innovative Product Award at the 2013 China International Innovation Expo and his multi-omics preventive health approach served thousands of clients. Prior to joining BGI, Dr. Gao spent over 14 years at a global leading life science company AB Sciex for a variety of executive roles, including Laboratory Director for Japan and China, China General Manager and Asia Pacific Senior Business Director driving over USD $100 million annual business and overseeing more than 100 staff. Prior to joining AB Sciex, Dr. Gao served as the Senior Scientist of Drug Metabolism at AstraZeneca, a world-class pharmaceutical company, where he contributed significantly the development of an anti-breast cancer drug Arimidex of over USD $1 billion annual revenue. Prior to joining AstraZeneca, Dr. Gao served as Scientist at Hemagen, an US regenerative medicine company. Dr. Gao received his MS and PhD degrees in Bioanalytical Chemistry from The Northeastern University in the US.
Dr. Gao is the member of American Society for Mass Spectrometry, Vice President of China International Talent Development Center Hong Kong Branch, Scientific Advisor of Beijing Union Hospital Clinical Laboratory, Senior Advisor of Shanghai Xuhui Hospital Clinical Laboratory, Visiting Professor of Hainan University, Scientific Advisor of Hainan Food and Drug Administration, Scientific Advisor and Honorary Director of Criminal Science Institute for Chongqing Public Security Bureau.